Zota Health Care enterprise value

·UnclassifiedChart ›
Share price at each year-end
Tap a line for its trendCurrentlast 12MFY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
4,298————
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
8.67.82.10.70.1
1.92.73.50.0—
28.728.75.614.78.9
4,320————
20.121.03.514.08.8
₹1,247.45————
65672523310589.2
4.4%4.0%2.4%14.0%9.9%
0.01×————
6.36×————
−15,744.38×————
−40.77×————
Reference items — trailing FY values
679539293180140
−0.318.5−5.77.67.3
−106−63.9−48.9−12.5−4.6
—−84.4−50.0−6.0−2.0
−84.4−84.4−50.0−6.0−14.5
—−85.7−50.1−6.0−14.5
—0.00.00.012.5
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

ZOTA₹1,241.10

Zota Health Care LImited

· Unclassified
₹ CrorePeersMARINEBETATHEJOMcap ₹4,298 Cr
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
In ₹ Crore except Per Share
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Current/LTM
TTM · last close
Market Capitalization————4,298.3
- Cash, Equiv & ST Investments0.10.72.17.88.6
+ Minority Interest—0.03.52.71.9
+ Total Debt8.914.75.628.728.7
Enterprise Value————4,320.3
Net Debt (memo)8.814.03.521.020.1
EV per Share————1,247.45
Total Capital89.2104.7232.8724.9656.2
Total Debt/Total Capital9.9314.022.413.964.38
Total Debt/EV————0.01
EV/Sales————6.36
EV/EBITDA————-15,744.38
EV/EBIT————-40.77
Reference Items — Trailing FY Values
Sales140.0180.5293.0538.7679.1
EBITDA7.37.6-5.718.5-0.3
EBIT-4.6-12.5-48.9-63.9-106.0
Operating Cash Flow-2.0-6.0-50.0-84.4—
Free Cash Flow-14.5-6.0-50.0-84.4-84.4
FCFF (free cash flow to the firm)-14.5-6.0-50.1-85.7—
Capital Expenditure12.50.00.00.0—
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.